* Exscientia PLC EXAI.OQ EXAI.O is expected to report
results on March 23.
* The Oxford Oxfordshire-based company is expected to
report
revenue of $4.175 million, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Exscientia PLC is
for a
loss of 24 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "Buy".
* Wall Street's median 12-month price target for Exscientia
PLC is
$27.5, above its last closing price of $16.35.
This summary was machine generated March 21 at 20:47 GMT. All
figures in US dollars unless otherwise stated